Clinical Trials Directory

Trials / Unknown

UnknownNCT02625064

Discovery of New Early Detection Biomarkers of Acute Respiratory Distress Syndrome

Status
Unknown
Phase
Study type
Observational
Enrollment
500 (estimated)
Sponsor
Xiangya Hospital of Central South University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The goal of this project is to find a series novel biomarkers by differential proteomic techniques that can improve the early diagnosis and develop a more efficient therapy to enhance ARDS patient survival rate.

Detailed description

Acute respiratory distress syndrome(ARDS) has a very poor prognosis and high mortality. To improve the early diagnosis of ARDS, there is an urgent need for novel biomarkers of ARDS. The goal of this project is to find a series novel biomarkers by differential proteomic techniques that can improve the early diagnosis and develop a more efficient therapy to enhance ARDS patient survival rate. Clinical data and blood sample were recorded before treatment and after treatment. Acute Physiology And Chronic Health Evaluation III (APACHE III) scores were calculated at enrolment. Studying blood specimens from different period ARDS patients by proteomic analysis. It can provide information on a complex composition of proteins that are differentially expressed, which could be used for discovering high sensitivity and specificity ARDS biomarker.

Conditions

Interventions

TypeNameDescription
OTHERBlood samples collection before treatment
OTHERBlood samples collection after treatment
OTHERlaboratory biomarker proteomic analysis

Timeline

Start date
2016-01-01
Primary completion
2019-01-01
Completion
2019-01-01
First posted
2015-12-09
Last updated
2015-12-09

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02625064. Inclusion in this directory is not an endorsement.